Tavros Therapeutics and Vividion Therapeutics Announce Strategic Collaboration to Discover and Enhance Targeted Oncology Programs Posted on October 12, 2022 | by Allen Pajar Partnership to define novel drug targets and biomarkers, in addition to positioning existing compounds